Stockreport

Sonnet BioTherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sonnet BioTherapeutics Holdings, Inc.  (SONN) 
PDF PRINCETON, NJ / ACCESSWIRE / October 4, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet BioTherapeutics"), a clinical-stage company [Read more]